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Abstract.  Receptor tyrosine kinases (RTKs) are 
grouped into subcategories based on shared sequence 
and structural  features.  Human group C  adenoviruses 
down-regulate EGF receptors,  which are members of 
the class I family of RTKs, during the early stages of 
infection.  Adenovirus appears to utilize a non- 
saturable intracellular  pathway since it causes EGF-R 
down-regulation even in cells that significantly overex- 
press EGF-R. Adenovirus-induced down-regulation is 
mediated by a  small hydrophobic molecule coded for 
by the E3 early transcription  region that has recently 
been localized to plasma membrane.  Here we examine 
intracellular  trafficking of other RTKs in adenovirus- 
infected cells, to better understand the molecular basis 
for the action of the E3 protein.  Although p185 ..... , 
which is a class I RTK closely related to the EGF 
receptor, is down-regulated in cells expressing physio- 
logical concentrations of this molecule, it is not down- 
regulated in tumor cell lines that significantly overex- 
press p185 ..... . Cell surface receptors for insulin and 
IGF1,  which are class II RTKs, are also reduced in 
ceils expressing the E3 protein,  although to a  slightly 
lesser extent than the EGF receptor.  Moreover, 
whereas EGF receptors are degraded between 3- and 
9-h postinfection, insulin and IGF1 receptors are 
degraded between 6- and  12-h postinfection under 
identical conditions.  In contrast to the class I and 
class II RTKs, there is no difference in the expression 
of the class III receptors for PDGF and aFGF in ceils 
infected with a virus with an intact E3 region versus a 
virus mutant with an internal deletion in the relevant 
E3 gene. These results suggest that the E3 protein 
provides an internalization  and degradative sorting sig- 
nal for some class I and class II RTKs, although 
down-regulation of class U RTKs is somewhat less 
efficient.  Molecular recognition of class I and class II 
RTKs during adenovirus infection may not be due 
strictly to amino acid structure,  however, since EGF-R 
but not p185 c-n~ is down-regulated in cells where it is 
significantly overexpressed. 
p 
ROTEIN transport and sorting  are essential  processes 
for many  cellular  functions.  Understanding  molec- 
ular  interactions  that  regulate  intraceUular  protein 
traffic is therefore  a fundamental  question in cell biology. 
The subject of this  study is an integral  membrane protein 
synthesized by group C human adenoviruses that regulates 
trafficking of the EGF receptor (EGF-R). ~  EGF-Rs are rap- 
idly cleared from the cell surface and degraded in cells ex- 
pressing  this protein (7, 25). Adenovirus  appears  to use a 
nonsaturable  intracellular  pathway, since it causes EGF-R 
down-regulation  even in cells that significantly  overexpress 
EGF-R (26). Although stability of nascent EGF-Rs is not af- 
fected, it is unclear whether EGF-Rs in the biosynthetic path- 
way actually reach the cell surface, or are diverted to a deg- 
radative pathway from a post-Golgi compartment (26).  The 
1. Abbreviations used in this paper: aFGF-R, aFGF receptor; EGF-R, EGF 
receptor; IGF1-R, IGF1 receptor; IN-R, insulin receptor; PDGF-R, PDGF 
receptor; pfu, plaque-forming  units; pi, postinfection;  RTK, receptor tyro- 
sine kinase; Tfn-R, transferrin receptor. 
adenovirus protein responsible for this effect is coded for by 
the E3 early region (7, 52), and has an approximate  molecu- 
lar weight of 13.7 kD. Several lines of evidence suggest that 
the  13.7-kD protein has  two membrane-spanning  regions, 
and that the NH2 and COOH termini  both reside in the cy- 
tosol (27, 33).  The NH2-terminal  membrane-spanning  re- 
gion is cleaved in the ER, giving a product of approximate 
molecular weight of 11.3 kD. This reaction is incomplete, 
however, and both proteins are detected during early infec- 
tion (27, 33). At present, it is unclear which is the bioactive 
form of the molecule. 
The EGF-R is one member of a family of cellular  recep- 
tors with intrinsic tyrosine kinase activity. Ligand activation 
of the receptor catalytic domain is essential for signal trans- 
duction (reviewed  in reference 55).  Although  all receptor 
tyrosine kinases (RTKs) have homologous cytosolic tyrosine 
kinase catalytic domains (55), members of this protein fam- 
ily have  been grouped into  subcategories  based on other 
shared sequence and structural  features.  EGF-R is a proto- 
typic class I RTK, consisting  of a single polypeptide chain 
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Other  class  I  RTKs  include the  proto-oncogene p185  ..... 
(also called erbB2) (11), and a recently identified molecule 
called erbB3 (35). Class 1I RTKs are disulfide-linked  hetero- 
tetramers  comprised  of two  a-  and  two  /3-subunits;  the 
cysteine-rich a-subunits are extracellular and bind ligand, 
whereas intrinsic tyrosine kinase activity resides in mem- 
brane-bound  /3-subunits.  Receptors  for  insulin  (57)  and 
insulin-like growth factor 1 (IGF1) (58)  fall into this cate- 
gory. Class III RTKs are characterized by an extracellular 
ligand-binding domain with immunoglobulin-like repeats, 
and a  cytosolic tyrosine kinase domain interrupted by a 
hydrophilic insertion of variable length. Class III RTKs in- 
clude receptors for PDGF (62),  colony stimulating factor-1 
(12),  and FGF (18). 
In  most  cases,  ligand-bound  RTKs  are  internalized 
through clathrin-coated pits (3, 43), although IN-Rs also en- 
ter the endocytotic  pathway via non-coated micropinocytotic 
invaginations in some cell types (22). Numerous studies have 
shown that RTK cytoplasmic domains contain signals impor- 
tant for efficient  internalization (8, 13, 44, 45, 51). Moreover, 
interactions between adjacent cytoplasmic domains may also 
contribute to the structure of internalization signals, since 
class  I  and class  III RTKs form oligomers after binding 
ligand (55). Once inside the cell, the post-endocytotic itiner- 
ary of RTKs is variable. EGF-Rs bound to EGF, for example, 
are mostly sorted to lysosomes (3),  whereas transforming 
growth factor a/EGF-R complexes are more likely to recycle 
to the cell surface (20). Postendocytotic trafficking pathways 
are also cell-type dependent. For instance, although EGF-Rs 
recycle in many cell types (19, 46), there is little if any recy- 
cling of this molecule in human fibroblasts (47). 
Based on limited sequence similarity between the COOH- 
terminal cytoplasmic region of 13.7 and 11.3 kD  and the 
EGF-R juxtamembrane domain, we have suggested that the 
E3 protein causes down-regulation by associating with unoc- 
cupied receptors  to mimic ligand-induced receptor oligo- 
merization  (7,  26).  It is  also possible  that viral protein- 
receptor aggregates are stabilized by interactions between 
a-helical domains in the plasma membrane (27, 39).  Since 
receptor oligomerization is a common feature of RTKs, the 
purpose of this study was to determine whether other recep- 
tors were similarly regulated during adenovirus infection. 
Results presented here show that the 13.7- and ll.3-kD pro- 
teins cause accelerated turnover of p185  .... in cells that ex- 
press physiological amounts of this protein, but not in tumor 
cell lines that significantly overexpress p185  .... . IN-Rs and 
IGF-1  receptors  (IGF1-Rs) are also down-regulated, while 
PDGF-Rs and aFGF receptors (aFGF-Rs) are not. We there- 
fore conclude that several members of the RTK protein fam- 
ily contain information making them targets for adenovirus- 
mediated down-regulation. Molecular recognition of class I 
and class II RTKs during adenovirus infection may not be 
due strictly to amino acid structure, however, since EGF-R 
but  not  p185  .....  is  down-regulated  in  cells  where  it  is 
significantly overexpressed. 
Materials and Methods 
Cell Lines, Transfections, and Viruses 
Human hepatocellular carcinoma-derived N:PLC/PRF/5 and Hep 3B cells, 
and human fetal lung-derived WI-38 cells,  were maintained using MEM 
supplemented  with 10% FBS and 2 mM glutamine.  Human breast carci- 
noma-derived SK-BR-3 and MDA-MB-453  cells were grown in McCoy's 
5a medium and L15 medium, respectively;  both media were supplemented 
with 10% FBS and 2 mM glutamine.  COS-7 cells (21) were maintained in 
DME supplemented with 10% FBS and 2 mM glutamine.  COS-7 cells were 
transfected with eukaryotic expression vectors containing either the entire 
coding sequence of the human EGF-R (56), or of the bek FGF-R (18; gift 
of M. Jaye, G. Crumley, and J. Schlessinger,  Rhone-Phonienc Rorer, King 
of Prussia, PA), using the N,N-bis(2-hydroxyethyl)-2-aminoethanesnifonic 
acid-buffered calcium phosphate method (32).  Virus stocks  were prop- 
agated  in spinner cultures  of human KB cells maintained with Joklik's- 
modified MEM supplemented  with 5 % horse serum and 2 mM glutamine, 
and titres were determined by plaque assay using human embryonic kidney 
293 cells (24) grown in DME supplemented with 10% FBS and 2 mM gluta- 
mine. in724 is an adenovirus type 5-adenovirus type 2-adenovirus type 5 
recombinant insertion mutant with increased distance between the 3' splice 
site of the E3 transcript that encodes the 13.7-kD protein (i.e., messngef), 
and the polyadenylation  site for the major E3 transcript seen in wild-type 
virus (message a) (10); consequently messagefis overproduced  at the ex- 
pense of message a  (4). d/753  is a virus mutant with an internal deletion 
of 207 nucleotides in the 13.7-kD open reading frame (4), and cells infected 
with d/753 do not produce 13.7-kD related proteins (52). Most acute infec- 
tions were carded out in the presence of arabinofuranosyl-cytosine  (20 
#g/ml) to enhance early viral protein synthesis  (31). 
Cross-linking Studies 
Cells were incubated with 125I-labeled EGF (8  x  106 cpm/ml, 'x,sp act = 
2  x  108 cpm/ttg of protein) in serum-fnee MEM supplemented with 0.1% 
(wt/vol) BSA for 15 min at 37~  Receptor-grade  mouse EGF (Toyobo Bio- 
chemicals, Osaka, Japan) was labeled with  n5I (carrier-free, >350 mCi/ml; 
New England Nuclear,  Wilmington, DE) using the chloramine-T  method. 
Cells were rinsed twice with PBS, and then incubated with 2 mM disuc- 
cinimidyl suberate (Pierce,  Rockford,  IL) in 0.1 M Hepes,  pH 7.4,  sup- 
plemented with 120 mM NaCI,  5 mM KC1, 8 mM glucose,  and 1.2 mM 
MgSO4,  for  15 rain at room temperature.  Disuccinimidyl suberate was 
quenched by a 5-rain incubation with 0.05 M Tris, pH 7.4, at room tempera- 
tune. Cell lysates prepared using 1% (wt/wt)  NP-40 in 0.1 M Tris, pH 6.8, 
supplemented with 15% (wt/wt) glycerol,  2 mM EDTA,  1 mM EGTA, 0.2 
mM PMSE 1 tiM leupeptin, and 1/tM pepstatin A, were separated by SDS- 
PAGE (38); detergents and protease inhibitors were from Boehringer Mann- 
heim Biochemicals  (Indianapolis,  IN). 
Cell Labeling and lmmunoprecipitation 
Cells  were  labeled with L-[35S]cysteine (200 #Ci/ml;  >600  Ci/mmol, 
New England Nuclear) in cysteine-  and serum-free medium as described 
in figure legends. Enzymatic cell surface labeling with 125I  was carried out 
using lactoperoxidase  (Calbiochem-Novabiochem,  La Jolla, CA). Cell ly- 
sates for immunoprecipitation with receptor antibodies were prepared using 
1% NP-40 as described above. Lysates for immunoprecipitatiun with rabbit 
synthetic peptide antisera specific for E3 proteins were prepared using 1% 
(wt/vol) NP-40, 0.5 % (wt/vol) sodium deoxycbolate, and 0.1% (wt/vol) SDS 
in 50 mM Tris, pH 8.0, 150 mM NaC1, 0.2 mM PMSF, and 1 #M each of 
leupeptin and pepstatin A; preparation and characterization  of the rabbit an- 
fisera are described in references  52 and 53. Immunoprecipitations were 
carried out with antibodies absorbed onto protein A-Sepharose CL-4B 
beads (Sigma Chemical Co., St. Louis, MO). The mAb EGF-RI is specific 
for human EGF-R (5, 59). The IR-1 (37) and OKT-9 (50) mAbs are specific 
for human insulin receptor (IN-R) and human transferdn receptor (Tfn-R), 
respectively, and were obtained from ATCC. IGF1-R and human pp185  c-neu 
mAbs were  purchased from Oncogene Sciences  (Manhasset, NY).  The 
PDGF receptor (PDGF-R)  was  immunoprecipitated with a  rabbit poly- 
clonal synthetic peptide antiserum (gift of J. Huang,  St.  Louis University 
Medical School, St. Louis, MO). Proteins were eluted from beads by boil- 
ing in Laemmli buffer, and separated  by SDS-PAGE (38). Gels containing 
L-[35S]cysteine-labeled  proteins were processed  for fluorography  using 
EnaHance  (New England Nuclear,  Boston, MA). 
Immunoblot Analysis 
Proteins were  resolved  by SDS-PAGE,  and transferred to nitrocellulose 
eleetrophoretically  according to Towbin et al. (54). Primary and secondary 
incubations were with the viral protein-specific rabbit antiserum described 
above (1:50) for 18 h at 4~  and 125I-labeled protein G (1  x  106 cpm/ml) 
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biochem) was radiolabeled by the chloramine-T method. A solution of 10 
mM "IYis,  pH 7.4, supplemented with 0.9% (wt/vol) NaC1, 1% (wt/vol) so- 
dium azide, 0.5% (wt/vol) Tween-20, and 1 mM EDTA was used to block 
and wash blots; reagents  were diluted with the same buffer supplemented 
with 3% fatty acid-free BSA (Sigma Chemical Co.). 
Indirect Immunofluorescence 
Ceils were seeded on coverslips  and infected 24 h later using 200 plaque- 
forming units (pfu) per cell. Coverslips were washed three times with PBS 
and then fixed with 3.7% paraformaldehyde (EM Reagents; Fort Washing- 
ton, PA) for 10 min at room temperature.  Cells were permeabilized during 
a second 10-rain incubation with 0.2% Triton X-100. Primary staining was 
carried out for I h at 37~  in a humidified chamber using a mAb from On- 
cogene Sciences Inc. (Manhasset, NY) specific for adenovirus 2 E1A pro- 
teins,  diluted  1:100. Secondary  staining with FITC-coupled  goat anti- 
mouse Ig (Cappel  Products,  Malvern, PA) diluted 1:500, was for 30 rain 
at 37"C. Reagents were diluted using PBS supplemented with 10% FBS and 
0.1% sodium azide. Immunofluorescence  was viewed using a Multiphot mi- 
croscope (Nikon, Melville, NY) equipped  with epi-fluorescence  optics. 
Phosphor Storage Autoradiography 
Ionizing radiation from autoradiograms was stored on a phosphor screen 
with a  linear dynamic range covering five orders of magnitude,  and re- 
emitted by exposing the screen to an 88-#m-diam helium-neon laser beam 
02; Phosphorlmager  TM, Molecular Dynamics Inc., Sunnyvale,  CA). Digi- 
tized images were analyzed using the ImageQuant  TM software package (Mo- 
lecular Dynamics). This program averages five measurements  of light emis- 
sion for each pixel location, to give a pixel value which is proportional to 
the amount of stored radiation. 
Radioligand Binding Assays 
Receptor grade mouse EGF and human recombinant aFGF (29; gift of M. 
Jaye) were radioiodinated by the chloramine-T  method as described above. 
Receptor  grade  porcine  t2SI-labeled insulin (2,200  Ci/mmol) was  pur- 
chased from New  England Nuclear.  Total binding was measured using 5 
ng/m1125I-labeled ligand, and non-specific binding was measured using the 
same amount of radiolabeled ligand plus 500 ng/rni nonradioactive ligand. 
Cells bound with ~251-aFGF  were pretreated for 15 min with 5 U/ml hepa- 
rin (Upjohn, Kalamazoo,  MI) on ice, to block low affinity binding to cell 
surface heparin sulfate proteoglycans (41). Cells were incubated with ligand 
for 30 rain at 37~  or for 45 rain at 40C, and solubilized with 1 M NaOH. 
For  lZ~l-labeled EGF binding, incubations and washes  were  carried out 
using serum-free MEM supplemented with 0.02 M Hepes, pH 7.4, and 0.1% 
BSA;  the same solution adjusted  to pH  8.0 was  used  to measure  L25I- 
labeled insulin binding. All determinations were made in duplicate.  Radio- 
activity was measured in a Cobra Auto-Gamma Counter (Packard  Instrs., 
Meriden, CT). 
Results 
13.7- and 11.3-kD E3 Protein Expression during 
Adenovirus-induced D~wn-regulation of the Class I 
RTK EGF-R 
Replicate dishes of  human hepatocellular carcinoma-derived 
N-PLC/PRF/5 cells (6) were infected with a  virus mutant 
which overproduces the 13.7- and ll.3-kD proteins (in724), 
so that time courses for viral protein expression and EGF-R 
down-regulation  could  be  measured  simultaneously.  The 
13.% and 11.3-kD proteins were first detectable at 5-h postin- 
fection (pi) (Fig. 1 A). The steady increase in 13.% and 11.3- 
kD protein expression is due in part to the fact that early viral 
protein expression was  enhanced in  this  experiment with 
arabinofuranosyl-cytosine (31).  In addition,  newly synthe- 
sized protein accumulates over time since the viral proteins 
are stable (27).  EGF-R down-regulation was measured by 
examining  the cell  surface for receptor molecules cross- 
Figure L 13.7- and ll.3-kD viral protein expression, and EGF-R 
internalization  and  degradation  in  adenovirus-infected N-PLC/ 
PRF/5 cells. Cells were infected with a virus mutant which overex- 
presses 13.7 and 11.3 kD (in724) using 200 pfu/cell, and harvested 
at hourly intervals pi. (.4) Cell lysates were immtmoprecipitated 
using a rabbit antiserum specific for the 13.7-  and ll.3-kD proteins. 
Immunoprecipitates  were  separated  by SDS-PAGE, transferred 
electrophoretically to nitrocellulose, and immunoblots were probed 
with the same rabbit antiserum,  followed by m25I-labeled protein 
G; the second reagent also stains IgG light chains from the rabbit 
antiserum.  (B) ~2SI-EGF  was cross-linked to in724-infected cells 
using disuccinimidyl suberate, and cell lysates were analyzed by 
SDS-PAGE; the lane to the extreme fight shows results for cells in- 
fected with an E3 deletion mutant (d/753), and cross-linked with 
~2~I-labeled EGF at  12-h pi.  (C) Lysates from cells  which had 
been prelabeled for 1 h with L-[3SS]eysteine  before being infected 
with in724 were immunoprecipitated with EGF-R1; EGF-R stabil- 
ity at 12-h pi in cells infected with d/753 is shown at the extreme 
right. Molecular weight standards: myosin, 200,000; B-galactosi- 
dase, 1  t6,250; phosphorylase B, 92,500; BSA, 66,200; ovalbumin, 
45,000;  carbonic  anhydrase, 31,000; soybean trypsin  inhibitor, 
21,500; and lysozyme, 14,400. 
linked to  ~25I-labeled EGF (Fig.  1 B),  and by looking for 
evidence  of increased  EGF-R  turnover  in  infected cells 
which had been prelabeled with L-[35S]cysteine (Fig.  1 C). 
Loss of EGF-R from the cell surface was first detectable be- 
tween 6 and 7 h pi, and was followed by increased EGF-R 
degradation ,~,1 h later. In contrast, there was no change in 
EGF-R binding capacity or stability when cells were infected 
using a virus mutant with a internal deletion in the 13.7-kD 
open reading frame (d/753). These data suggest that there is 
an interval of ,,ol to 2 h between the onset of 13.7- and 11.3- 
kD protein expression, and EGF-R down-regulation. Con- 
sidering that the 13.7- and 11.3-kD proteins both originate in 
the ER (27), this lag probably represents the time required 
for intracellular transit of the viral proteins to the cell sur- 
face, where the viral proteins are known to localize (27). 
These results  suggest that  13.7- and  ll.3-kD  proteins act 
directly in the plasma membrane, or by causing translocation 
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were  prelabeled  with  L-[35S]cysteine for 1 h,  and then  infected 
with a virus mutant which overexpresses 13.7 and 11.3 kD (in724) 
or a virus mutant with an internal deletion  in the  13.7-kD open- 
reading frame (d/753), using 200 pfu/cell.  Cell lysates were pre- 
pared at  18-h pi.  Lysates were  immunoprecipitated  with  mAbs 
specific for EGF-R (.4 and B) or p185  .... (A, B, and C). Aliquots 
containing equal cpm were immunoprecipitated from cells infected 
with  the two viruses.  (A) WI-38  cells;  (B) SK-BR-3 cells;  (C) 
MDA-MB-453 cells. 
Figure  3. Synthesis of  E3-encoded viral proteins following infection 
with a group C adenovirus. Cells listed in the figure were infected 
with the virus mutant in724 using 200 pill per cells, and then la- 
beled with L-[3sS]cysteine  for 5 h starting at 7-h pi for all cells ex- 
cept WI-38, which were labeled  starting  at 12-h pi.  Cell lysates 
were immunoprecipitated  using rabbit antisera specific for either 
the 13.7- and ll.3-kD proteins; or a second protein encoded by the 
E3 region referred to as 14.5 K (53). 
of sequestered cellular proteins that mediate internalization 
and degradation of unoccupied EGF-Rs. 
Stability of the Class I RTK p185  ..... in 
Adenovirus-infected Cells Expressing the E3 13.7- and 
H.3-RD Proteins 
Expression of the p185  ..... proto-oncogene during adenovi- 
rus infection was examined in normal human diploid fibro- 
blasts and two breast carcinoma-derived cell lines, SK-BR-3 
and MDA-MB-453. Compared to human fibroblasts, p185  .... 
is produced at high levels in the SK-BR-3 and MDA-MB-453 
cell lines, due to gene amplification and mRNA overexpres- 
sion (34).  There are reports that the adenovirus immediate 
early  E1A  protein  down-regulates  p185 ....  by  transcrip- 
tional  repression  (61).  To  circumvent the  E1A  effect,  we 
therefore measured stability of molecules synthesized before 
infection.  When WI-38 cells were prelabeled with L-[35S]- 
cysteine and then infected with adenovirus,  the amount of 
EGF-R and p185 c-~ present at 24-h pi was significantly re- 
duced in cells expressing the E3  13.7- and ll.3-kD proteins, 
compared to cells infected with the 13.7-kD deletion mutant 
(Fig. 2 A). In contrast, there was essentially no difference in 
p185 ..... protein abundance in either SK-BR-3 (Fig. 2 B) or 
MDA-MB-453 (Fig. 2  C) cells infected with the same two 
viruses. EGF-Rs were, however, down-regulated in the SK- 
BR-3 cells infected with in724, suggesting that the E3 protein 
was being expressed. Since MDA-MB-453 cells lack EGF- 
Rs, we also examined infected cells directly for evidence of 
early  viral protein  expression.  When  MDA-MB-453  cells 
were fixed and stained using a mAb specific for the adenovi- 
rus  immediate early EIA proteins  at 8-h pi,  for example, 
there was intense nuclear immunofluorescence indicative of 
E1A  expression  in  essentially  all  of  the  cells  (data  not 
shown). Moreover, all of the cell lines which were examined 
for p185  .....  expression  synthesized  the  13.% and  ll.3-kD 
proteins, as well as a second E3-encoded protein referred to 
as 14.5K which is not deleted in d/753 (58), shortly after vi- 
ral infection (Fig.  3).  These results suggest that p185  .... is 
down-regulated by the E3 protein, unless it is significantly 
overexpressed. This is in contrast to previous results show- 
ing  that  adenovirus  uses  a  non-saturable  pathway  when 
down-regulating EGF-Rs (26;  also see Fig.  8 A). 
Cell Surface Expression of the Class H RTK 
Receptors for Insulin and IGF1 in Adenovirus-infected 
Cells Expressing the E3 13.7- and 
11.3-kD Proteins 
We  first  asked  whether  IN-R  or  IGF1-R expression  was 
affected by adenovirus, by examining cell surface expression 
of these two molecules in N-PLC/PRF/5 ceils. Cells were in- 
fected with in724 or d/753,  and then labeled enzymatically 
with 125I at 20-h pi. When immunoprecipitates formed using 
receptor-specific mAbs were compared, surface expression 
of the receptors for insulin and IGF-I was diminished in cells 
expressing 13.7 and 11.3 kD compared to cells infected with 
the 13.7-kD deletion mutant (Fig. 4). IN-R and IGFI-R sur- 
face expression in in724-infected cells was not, however, re- 
duced to the same extent as EGF-R. Since cell surface IGFI- 
Rs  are  difficult  to  measure  accurately  with  radiolabeled 
ligand  due  to  the  presence of abundant  low-affinity IGFI 
binding  proteins  (2),  receptor  down-regulation  was  esti- 
Figure 4.  Cell  surface  expression  of IN-R and  IGF1-R during 
adenovirus infection. N-PLC/PRF/5 cells were infected with in724 
or d/753 using 200 pfu/cell. Intact monolayers were labeled enzy- 
matically  with  t25I at 20-h pi. Cell lysates were immunoprecipi- 
tated with mAbs specific for EGF-R,  IN-R, IGF1-R, and Tfn-R. 
Aliquots  containing  equal  cpm were  immunoprecipitated  from 
cells infected with the two viruses. In addition to the extracellular 
IN-R and IGF1-R ex-subunits, the ~-subunits are also labeled in this 
protocol due to the presence of several tyrosine residues in the ex- 
tracellular domain of each of these subunits (57, 58; see also refer- 
ence 37). 
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Fig. 5 by Phosphor Storage Autoradiography 
Normalized  % down- 
Receptor  d/753'  in724  ~  in724~:  regulationw 
EGFR  534  •  16  77  •  2.4  54 
INR 
~-subun~  117  •  8.8  51  •  1.0  36 
fl-subunk  73  •  1.4  35  •  2.6  24 
IGFIR 
~-subun~  680  •  16  296  •  15  207 
~-subun~  288  •  10  123  •  9.5  86 







* Volume integration of pixel values in a defined area with background sub- 
tracted.  Pixel values are arbitrary units that are proportional to the amount of 
radiation  stored  and  re-emitted  from phosphor screens.  Values in the table 
represent the mean of three independent determinations for each band  +SEM, 
and have been multiplied by 10  -3 . 
Raw values for in724 were normalized assuming equivalent TfnR expression 
in cells infected with either virus (x0.70). 
w 100  -  (normalized value for in724 -  raw value for d/753). 
mated using phosphor storage autoradiography (30) to quan- 
titate immunoprecipitates of 125I-labeled receptor proteins. 
Results for the gel shown in Fig. 4 are given in Table I. The 
value obtained for the band representing Tfn-R in cells in- 
fected with d/753 was '~30% less than what was measured 
for cells infected with in724. Values for the other proteins 
were  therefore  normalized  assuming  equivalent  Tfn-Rs, 
since Tfn-R expression is  not affected by adenovirus (7). 
Based on this  analysis,  cell surface EGF-R expression in 
cells expressing the 13.7- and ll.3-kD proteins was reduced 
by ~90%, compared to a 70% reduction for IN-R and IGF1-R. 
Even without normalization, IN-R and IGF1-R surface ex- 
pression was down-regulated after infection with in724 by 
more than 50%. Similar results were obtained in three inde- 
pendent experiments with N-PLC/PRF/5 cells, and in a sec- 
ond human hepatoceUular carcinoma-derived cell line Hep 
3B (not shown). 
IN-R and IGF1-R Protein Stability during the Early 
Stages of  Adenovirus Infection 
IN-R and IGFI-R protein stability was examined by compar- 
ing receptor expression in cells prelabeled with L-[35S]cys- 
teine for 1 h  and then infected with adenovirus.  Whereas 
EGF-R degradation occurred between 3- and 9-h pi in cells 
expressing the  13.7- and  ll.3-kD proteins, increased turn- 
over of the IN-R was most evident between 6- and 12-h pi 
(Fig.  5).  In contrast, there was essentially no turnover of 
EGF-R or IN-R in cells infected with the 13.7-kD deletion 
mutant. Similar results were obtained when IGF1-R stability 
during adenovirus infection was examined (Fig.  5).  Tfn-R 
stability was measured as a control for general membrane 
protein stability; while there was  some Tfn-R turnover at 
15-h  pi,  it  occurred  to  an  essentially  equivalent  extent 
regardless of which virus was used for infection. It therefore 
appears that loss of surface IN-Rs and IGF1-Rs  during the 
early stages of adenovirus infection is due to increased turn- 
over of these molecules. Degradation of class II RTKs, how- 
ever, occurs 2 to 3 h  after EGF-R degradation in cells ex- 
pressing the 13.7- and  ll.3-kD proteins. 
Figure 5. Comparison of EGF-R, IN-R, IGF1-R, and Tfn-R stabil- 
ity during adenovirus infection. N-PLC/PRF/5 cells were labeled 
with L-[35S]cysteine  for 1 h, and then infected with in724 or d/753, 
using 200 pfu/cell. Cell lysates prepared at the times indicated in 
the figure were immunoprecipitated for EGF-R, IN-R, IGF1-R, or 
Tfn-R. 
One possible explanation for these results is that class II 
RTKs are somehow "dragged" into a  degradative pathway 
when  EGF-Rs  are down-regulated in  cells expressing the 
13.7- and  ll.3-kD  proteins.  We  therefore asked  whether 
IN-R  surface  expression  was  regulated  by  adenovirus  if 
EGF-Rs  were  down-regulated by ligand  before infection. 
This was achieved by stimulating uninfected N-PLC/PRF/5 
cells with a saturating concentration of nonradioactive EGF 
(100 ng/ml) for 1 h, and then replenishing the medium with 
the same concentration of EGF every 3 h during subsequent 
infection. ~25I-labeled  EGF binding capacity was reduced by 
>90%  in cells infected with d/753 receiving this treatment 
for 18 h  (Fig. 6, top). When a trace amount of ~5I-labeled 
EGF was added to infected cells 18-h pi, as expected EGF-R 
binding capacity was reduced by >90% in cells infected with 
in724, compared to cells infected with d/753 (Fig. 6, top); 
there  was  no  significant  reduction  in  binding  by  in724- 
infected cells treated with saturating amounts of nonradioac- 
tive EGE  When IN-R binding capacity was  measured in 
cells infected with in724, the reduction in surface IN-Rs was 
essentially the same regardless of whether cells had been 
stimulated with nonradioactive EGF to down-regulate EGF-R 
independent of adenovirus infection (Fig.  6, bottom). The 
slight  difference in  125I-labeled insulin  binding  by d/753- 
infected cells  plus  and  minus  EGF  was  not  statistically 
significant. Taken together with results showing that EGF-R 
and IN-R are degraded with slightly different kinetics during 
adenovirus  infection (Fig.  5),  these  findings  suggest that 
adenovirus-mediated down-regulation of EGF-R and IN-R 
are independent events. 
Expression of  Class III RTKs during 
Adenovirus Infection 
The class III RTK PDGF-R is expressed by a variety of cells 
of mesodermal origin, including human diploid fibroblasts. 
We therefore infected human fetal lung-derived WI-38 cells 
with a wild-type group C recombinant adenovirus which ex- 
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insulin  binding  by  N-PLC/ 
PRF/5  ceils  infected  with 
adenovirus.  Cells were  in- 
fected with in724 or d/753, us- 
ing 200 pfu/cell (t~, -EGF). 
Duplicate dishes were treated 
with  100  ng/ml nonradioac- 
tive EGF for 1 h prior to infec- 
tion, and every 3 h thereafter 
([],  +EGF).  Binding assays 
were carried out at  18 h pi; 
non-specific binding was mea- 
sured using a 500-fold excess 
of nonradioactive ligand, and 
was  subtracted  from  toted 
binding to give specific bind- 
ing.  All  measurements were 
done  in duplicate;  the  SEM 
bars in the figure are sums of 
SEMs for total and non-spe- 
cific binding. 
presses 13.7 and 11.3 kD (rec700), and the 13.7-kD deletion 
mutant (d/753). When infected monolayers were labeled en- 
zymatically with ~25I at 20-h pi, EGF-R was clearly down- 
regulated in cells expressing the 13.7- and ll.3-kD proteins 
(Fig. 7). There was, however, essentially no difference in cell 
surface PDGF-R expression in WI-38 cells infected with ei- 
ther virus.  Experiments to measure RTK stability during 
adenovirus infection showed that 13.7- and ll.3-kD expres- 
sion also caused turnover of EGF-R but not PDGF-R (data 
not shown). 
Another member of the class HI RTK family, the FGF-R, 
was  also examined for down-regulation during adenovirus 
infection.  In  these  experiments,  COS-'/  cells  were  trans- 
fected with a eukaryotic expression plasmid containing the 
cDNA for human bek FGF-R regulated by the human CMV 
promoter to allow for transient expression, and then infected 
with adenovirus 48 h later. COS-7 ceils were used because 
they lack detectable levels of endogenous FGF-R (unpub- 
lished  result),  and  also  are  efficient  hosts  for  human 
adenoviruses since SV-40 T antigen provides a helper func- 
tion for adenovirus growth in monkey cells (31). To demon- 
strate the feasibility of this  approach,  we first transfected 
COS-7  cells with  a  human  wild-type EGF-R  eDNA  also 
regulated by the human CMV promoter. When cells trans- 
fected with the EGF-R eDNA were infected with adenovirus, 
EGF-Rs were clearly down-regulated in ceils expressing the 
E3 protein despite being overexpressed compared to the en- 
dogenous monkey EGF-R (Fig. 8 A). In COS-7 ceils trans- 
fected with a plasmid coding for bek FGF-R (18), the specific 
cpm bound by cells infected with the virus mutant that over- 
produces  13.7 and  11.3 kD  was  not significantly different 
than the value obtained for cells infected with the 13.7-kD de- 
letion mutant (Fig.  8 B).  In this experiment, endogenous 
EGF-Rs  were  also  measured  to  control  for  any  adverse 
effects on the function of the E3 protein due to transfeetion. 
Similarly, endogenous EGF-Rs but not transiently expressed 
bek FGF-Rs were degraded in COS-'/cells expressing the 
13.7- and 11.3-kD proteins (data not shown). Taken together 
with results for PDGF-R, these experiments show that the 
13.7- and  ll.3-kD proteins do not down-regulate either of 
these class HI RTKs. 
Figure 7. Cell surface expression of  the PDGF-R during adenovirus 
infection. WI-38 cells were infected with the wild-type group C vi- 
rus rec700 or d/753, using 200 pfu/cell. Cells were enzymatically 
labeled with 1251 at 20-h pi, and cell lysates were immunoprecipi- 
tated with mAbs specific for EGF-R or Tfn-R, or a rabbit poly- 
cloned antiserum specific for PDGF-R; ediquots containing equal 
cpm were immunoprecipitated from cells infected with the two 
viruses. 
Discussion 
We show here that in addition to EGF-R, p185  .... ,  IN-R, 
and IGF1-R enter a  degradative pathway during the early 
stages of adenovirus infection independent of ligand. Down- 
regulation  of these  RTKs  is  linked  to  expression  of an 
adenovirus region E3-encoded 13.7-kD protein that localizes 
to the plasma membrane (27). A second proteolytieally de- 
rived 11.3-kD protein is also expressed at the cell surface (27, 
33), and it is currently unclear which form of the molecule 
is bioactive. We have shown previously that the kinetics of 
EGF-R down-regulation is positively regulated by the amount 
of viral protein expressed (26), suggesting that there may be 
a  stoichiometric  relation  between  these  two  molecules. 
Based on the subcellular localization of  the 13.7- and ll.3-kD 
proteins (27) and the short interval between E3 protein syn- 
thesis and RTK degradation (Fig. 1), it is likely that these vi- 
ral  proteins act directly in  the plasma  membrane.  Local 
changes in the density of an accessory molecule have been 
shown  to  be  sufficient to  initiate  acetylcholine receptor 
clustering at neuromuscular  junctions during synaptogenesis 
(48). Perhaps the E3 proteins studied here behave similarly, 
although there must still be a mechanism that accounts for 
common recognition of class I and class 1I RTKs. Although 
EGF-Rs are better targets for adenovirus-mediated down- 
regulation than the class II RTKs, the ability of these mole- 
cules to be down-regulated by a common mechanism further 
distinguishes them from the class 111 RTKs examined here. 
At present, the molecular basis of  this specificity is not clear. 
We  have  noted  previously that  there is  limited  sequence 
similarity between the COOH-terminal cytoplasmic region 
of 13.7- and ll.3-kD and the EGF-R juxtamembrane domain 
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virus following transfeetion with cDNAs coding for human EGF-R 
or bek FGF-R. (.4) Untransfected COS-7 cells (left) or COS-'/cells 
transfeeted with a eDNA encoding the wild-type human EGF-R 
(right) were infected with in724 (13) or d/753 (13) were assayed for 
nSI-labeled EGF binding  capacity. Assays are shown using  the 
same scale to illustrate that the transfeeted eDNA is overexpressed 
compared to endogenous monkey EGF-Rs. (B) COS-7 cells trans- 
feeted with a eDNA coding for the bek FGF-R were infected with 
in724 (ca) or d/753 (ca), and assayed for ~25I-labeled EGF by en- 
dogenous EGF-Rs, or ~-aFGF by transiently expressed aFGF-Rs. 
Transfected cells were infected 48 h after DNA was added, and as- 
sayed for ligand binding  18- to 20-h pi. All measurements were 
done in duplicate, and SEM bars are indicated in the figure. 
(7). Close examination of the corresponding regions of the 
IN-R and IGFI-R did not reveal any significant sequence ho- 
mology or shared predicted secondary structure (not shown). 
We are currently using a molecular approach to more pre- 
cisely identify which regions in class I and class II RTKs are 
required for adenovirus-mediated down-regulation. 
Internalization  recognition signals have been identified in 
the cytoplasmic tails of several receptors that associate with 
clathrin-coated pits independent of ligand binding,  such as 
the low-density lipoprotein receptor (9).  These signals are 
characterized by a tyrosyl residue preceded by a cluster of 
amino acids frequently found in a B-turn (36). It is generally 
thought that tyrosine recognition signals bind receptors to 
clathrin-associated proteins. Receptors for EGF and IN, on 
the other hand, concentrate in clathrin-coated pits after bind- 
ing ligand (3, 43). Although tyrosine recognition signals are 
conserved  in  most  RTKs,  the  only  one  linked  to  ligand- 
induced internalization to date maps to the region surround- 
ing Tyr-960 in the juxtamembrane region of the IN-R B-sub- 
unit;  IN-R mutants with phenylalanine  substituted for Tyr- 
960 are still internalized, but at a rate that is much lower than 
for wild-type IN-R (1). The three consensus tyrosine recog- 
nition signals located near the EGF-R COOH-terminus (9) 
are nonessential for ligand-induced internalization  (i.e., ref- 
erence  13). Interestingly,  one of the tyrosyl residues in the 
cytoplasmic tails of the 13.7- and ll.3-kD proteins lies in a 
predicted  fl-turn  (27).  This  raises  the  possibility  that  the 
13.7- and ll.3-kD proteins anchor class I and class II RTKs 
to clathfin-associated proteins,  although  it is not currently 
known whether adenovirus utilizes a clathrin-dependent  or 
-independent pathway. Association with the adenovirus pro- 
teins may also unmask previously unidentified cryptic inter- 
nalization signals shared by class I and class II RTKs. In ei- 
ther case, viral protein-RTK complexes might be stabilized 
by helix-helix interactions in the plasma membrane (27, 39). 
It is also possible that sequestered cellular proteins which 
cause unoccupied RTKs to be down-regulated are translo- 
cared to the plasma membrane following 13.7- and  ll.3-kD 
expression. 
Interestingly,  although  EGF-R  and  p185  ~-~  are  closely 
related class I  RTKs, p185  c-~ is not a  target for  13.7- and 
11.3-kD--mediated down-regulation in ceils where it is over- 
expressed. If the endocytotic pathway used by adenovirus is 
saturable  and  rate  limiting,  there  is  the  possibility  that 
p185  ~  down-regulation is not easy to detect since the cells 
used in  this  study  significantly  overexpress p185  ~  This 
seems unlikely,  however, since EGF-R down-regulation by 
adenovirus infection in cells which have very high levels of 
that molecule is very efficient (27), despite lowered rates of 
EGF-R internalization in these cells during stimulation with 
EGF (60).  In contrast to EGF-R (15), p185  ~  is constitu- 
tively active in a variety of cells where it is overexpressed 
(14),  including  those  studied  here  (unpublished  data). 
p185  ~'- is also constitutively active in transfected NIH 3T3 
cells overexpressing chimeric RTKs with EGF-R extraeeilu- 
lar domains (16). It may therefore be that the mechanism of 
action utilized by the 13.7- and ll.3-kD proteins is not com- 
patible with class I RTKs that have high levels of kinase ac- 
tivity. 
In contrast to most viral proteins that regulate subcellular 
routing  of  RTKs,  the  E3  proteins  studied  here  are  not 
secreted growth factors that recognize RTK ligand-binding 
domains (26).  One other viral protein has been identified, 
the E5 transforming protein of bovine papillomavirus (BPV- 
E5) (17), that has similar structural properties. Like the E3 
proteins (27), BPV-E5 is a disulfide-linked dimer found in 
cell membranes including the plasma membrane (28). R has 
recently been shown that BPV-E5 associates with the channel 
protein component of vacuolar H+-ATPases (23). This raises 
the possibility that BPV-E5 regulates endosornal pH, so that 
recycling is favored at the expense of  postendocytotic sorting 
to lysosomes. This would account for the observation that in 
contrast to adenovirus-infected cells, ligand-bound RTKs are 
activated  but not degraded  in  cells transfected with  BPV- 
E5--contalniog plasmids  (40, 42). 
The purpose served by 13.7- and 11.3-kD expression dur- 
ing  adenovirus  infection  is  unclear.  Although  group  C 
adenoviruses  primariiy  infect  pulmonary  epithelial  cells, 
there can be widespread dissemination in severe infections, 
particularly to liver (49). Considering that the E3 transcrip- 
tion region is not obligatory for viral replication (31),  RTK 
down-regulation in these tissues is probably not a signal to 
increase  metabolism  in  nonproliferating  cells  during  an 
acute  infection.  Recent  evidence  that  adenovirus  down- 
regulates  EGF-Rs  without  enhancing  intrinsic  autophos- 
phorylating  activity  is  consistent  with  this  interpretation 
(Carlin,  C.  R.,  S. Felder,  and E  H.  Hoffman, manuscript 
submitted for publication).  Alternative possibilities are that 
there is some benefit derived that helps counter host anti- 
viral  defense  mechanisms,  or  that  establishes  host-tissue 
tropisms of ditferent adenoviruses. It is also possible that the 
13.7- and ll.3-kD proteins are expressed periodically when 
latent virus is reactivated. If IN-R expression is affected in 
vivo,  it  is  interesting  to  consider  whether  intermittent 
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glucose intolerance. Since viral proteins often usurp func- 
tions of cellular counterparts, the unique structure of these 
adenovirus proteins suggest that there may be alternative 
pathways  for intracellular RTK trafficking. Understanding 
physiological states  when expression of a  similar ligand- 
independent pathway is  beneficial may help  explain why 
these E3 proteins have evolved in human adenoviruses. 
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